---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-007943"
form_type: "8-K"
ticker: "BYSI"
cik: "0001677940"
company_name: "BeyondSpring Inc."
filed_at: "2025-12-15T23:59:59+00:00"
generated_at: "2026-05-16T13:13:57.866936+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# BeyondSpring delays second closings of SEED Therapeutics share sale to H1 2026

## Summary
- Second closings under Preferred Share Purchase Agreement for SEED Therapeutics Series A-1 shares postponed from Dec 2025 to H1 2026.
- Three investors (Winning View, FULL TECH, Mapfil) to purchase 3,103,055 shares for ~$13.2M at $4.25/share, now expected H1 2026.
- Total deal value for all 8,333,637 shares is $35.4M; no assurance that second closings will not be further delayed.

## SEC filing metadata
- accession: 0001171843-25-007943
- form_type: 8-K
- ticker: BYSI
- cik: 0001677940
- company_name: BeyondSpring Inc.
- filed_at: 2025-12-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677940/000117184325007943/0001171843-25-007943-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677940/000117184325007943/f8k_121525.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-007943
- JSON: https://secwatch.observer/filing/0001171843-25-007943.json
- Plain text: https://secwatch.observer/filing/0001171843-25-007943.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.